These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 5929469)

  • 21. Human cell mediated immunity to porins from Salmonella typhi.
    Blanco F; Isibasi A; Raúl González C; Ortiz V; Paniagua J; Arreguín C; Kumate J
    Scand J Infect Dis; 1993; 25(1):73-80. PubMed ID: 8384733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enteric fever due to Salmonella typhi and paratyphi A a neglected and emerging problem.
    Wilde H
    Vaccine; 2007 Jul; 25(29):5246-7. PubMed ID: 17560692
    [No Abstract]   [Full Text] [Related]  

  • 23. Appraisal of typhoid vaccine in experimentally infected human subjects.
    Hornick RB; Woodward TE
    Trans Am Clin Climatol Assoc; 1967; 78():70-8. PubMed ID: 6028241
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment of typhoid and paratyphoid with chloramphenicol and vaccine].
    Mariani I
    Med Glas; 1966 Oct; 20(10):383-5. PubMed ID: 4962658
    [No Abstract]   [Full Text] [Related]  

  • 25. [Anti-typhoid vaccine prophylaxis and vaccine therapy in carrier states and in typhoid fever. I. Convalescent carriers].
    Buşilă VT; Vasilescu I; Vâlceanu M; Fitărău A; Pintea L
    Microbiol Parazitol Epidemiol (Bucur); 1970; 15(4):305-11. PubMed ID: 5456200
    [No Abstract]   [Full Text] [Related]  

  • 26. [Typho-paratyphoid fever at the military teaching hospital Mohammed V. Sensitivity to antibiotics and lysotyping of S. typhi strains isolated between 1976 and 1978].
    Baaj AJ; Nejmi S; El Mellouki W
    Maghrib Tibbi; 1981 Mar; 3(1):547-53. PubMed ID: 6808251
    [No Abstract]   [Full Text] [Related]  

  • 27. [The problem of control of anti-typhoid vaccines. V. The immunogenic value of antityphoid vaccines in relation to the antigenic structure of the strains used in their preparation].
    Gabbrielli G; Buzzanca E
    Boll Soc Ital Biol Sper; 1968 Apr; 44(8):725-8. PubMed ID: 5698500
    [No Abstract]   [Full Text] [Related]  

  • 28. An outbreak of typhoid fever, Xing-An County, People's Republic of China, 1999: estimation of the field effectiveness of Vi polysaccharide typhoid vaccine.
    Yang HH; Kilgore PE; Yang LH; Park JK; Pan YF; Kim Y; Lee YJ; Xu ZY; Clemens JD
    J Infect Dis; 2001 Jun; 183(12):1775-80. PubMed ID: 11372030
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The novel oral typhoid vaccine M01ZH09 is well tolerated and highly immunogenic in 2 vaccine presentations.
    Kirkpatrick BD; Tenney KM; Larsson CJ; O'Neill JP; Ventrone C; Bentley M; Upton A; Hindle Z; Fidler C; Kutzko D; Holdridge R; Lapointe C; Hamlet S; Chatfield SN
    J Infect Dis; 2005 Aug; 192(3):360-6. PubMed ID: 15995948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Typhoid vaccine development with a human challenge model.
    Feasey NA; Levine MM
    Lancet; 2017 Dec; 390(10111):2419-2421. PubMed ID: 28965714
    [No Abstract]   [Full Text] [Related]  

  • 31. TREATMENT OF TYPHOID CARRIERS WITH AMPICILLIN.
    CHRISTIE AB
    Br Med J; 1964 Jun; 1(5398):1609-11. PubMed ID: 14134488
    [No Abstract]   [Full Text] [Related]  

  • 32. A multi-country cluster randomized controlled effectiveness evaluation to accelerate the introduction of Vi polysaccharide typhoid vaccine in developing countries in Asia: rationale and design.
    Acosta CJ; Galindo CM; Ali M; Elyazeed RA; Ochiai RL; Danovaro-Holliday MC; Page AL; Thiem VD; Jin Y; Park JK; Lee H; Puri MK; Ivanoff B; Agtini MD; Soeharno R; Simanjuntak CH; Punjabi NH; Canh DG; Sur D; Nizami Q; Manna B; Bai-qing D; Anh DD; Honghui Y; Bhattacharya SK; Bhutta Z; Trach DD; Xu ZY; Pang T; Donner A; Clemens JD
    Trop Med Int Health; 2005 Dec; 10(12):1219-28. PubMed ID: 16359401
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Typhoid epidemic at Pozzallo, with special reference to the fecal elimination of Salmonella typhi in typhoid subjects treated with chloromycetin].
    CEFALU M; GIUSTOLISI G
    Ann Sanita Pubblica; 1950; 11(1):121-31. PubMed ID: 15419570
    [No Abstract]   [Full Text] [Related]  

  • 34. [CHLORAMPHENICOL RESISTANCE OF STRAINS OF SALMONELLA TYPHI ISOLATED FROM TYPHOID FEVER PATIENTS HOSPITALIZED AT THE HOSPITAL OF INFECTIOUS AND CONTAGIOUS DISEASES IN THE CITY OF GUAYAQUIL IN THE YEARS 1961, 1962 AND 1963].
    VILLAMARDESANDOVAL O
    Rev Ecuat Hig Med Trop; 1963; 20():37-42. PubMed ID: 14189227
    [No Abstract]   [Full Text] [Related]  

  • 35. [Clinical evaluation of the passive hemagglutination test in typhoid fever].
    Kossakiewicz-Sulkońska B
    Przegl Epidemiol; 1970; 24(4):483-9. PubMed ID: 5495312
    [No Abstract]   [Full Text] [Related]  

  • 36. Antibody response to the protein antigens of "Salmonella typhi" during typhoid infection and following vaccination with a live oral typhoid vaccine Ty21a.
    Chau PY; Tsang RS
    Dev Biol Stand; 1983; 53():29-31. PubMed ID: 6873471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Typhoid vaccine.
    John TJ
    Indian Pediatr; 1995 Mar; 32(3):391-3. PubMed ID: 8613306
    [No Abstract]   [Full Text] [Related]  

  • 38. Enteric and salmonella infection: the carrier state.
    McCoy JH
    Soc Appl Bacteriol Symp Ser; 1974; 3(0):221-8. PubMed ID: 4612723
    [No Abstract]   [Full Text] [Related]  

  • 39. [Research on the sensitivity in vitro to chloramphenicol of strains of Salmonella typhi isolated from children with typhoid].
    BURGIO GR; PURRAZZELLA G
    Boll Soc Ital Biol Sper; 1950 Jun; 26(6):912-4. PubMed ID: 14801253
    [No Abstract]   [Full Text] [Related]  

  • 40. Mouse challenge with Salmonella typhosa T 5501 in testing the potency of typhoid vaccines.
    FISEK NH; GOREN S; AKYAY N
    Bull World Health Organ; 1959; 20(6):1257-9. PubMed ID: 13823157
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.